Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors

Published:2024-01 Issue: Volume:263 Page:115923
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wu Aijia,Shi Kunyu,Wang Jiaxing,Zhang Ruofei,Wang Yuxi

Funder

Sichuan Province Science and Technology Support Program

Ministry of Science and Technology of the People's Republic of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference176 articles.

1. A review: mechanism of action of antiviral drugs;Kausar;Int. J. Immunopathol. Pharmacol.,2021

2. RdRp inhibitors and COVID-19: is molnupiravir a good option?;Hashemian;Biomed. Pharmacother.,2022

3. The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2;Jin;Biochem. Biophys. Res. Commun.,2021

4. Protease targeted COVID-19 drug discovery and its challenges: insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors;Amin;Bioorg. Med. Chem.,2021

5. Recent drug development and medicinal chemistry approaches for the treatment of SARS-CoV-2 infection and COVID-19;Ghosh;ChemMedChem,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression;European Journal of Medicinal Chemistry;2024-11

2. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

3. Bacterial Membrane Vesicles as a Novel Vaccine Platform against SARS-CoV-2;Current Microbiology;2024-08-20

4. Organometallic–Erlotinib Conjugates Active against Lung Cancer Cells and as Emerging Virus Entry Inhibitors;Organometallics;2024-07-22

5. Selective Termination of Autophagy-Dependent Cancers;Cells;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3